| Overseeing research on therapeutic cloning: a private ethics board responds to its critics.: An article from: The Hastings Center Report | Digitalby Ronald M. Green (Author), Kier Olsen DeVries (Author), Judith Bernstein (Author), Kenneth W. Goodman (Author), Robert Kaufmann (Author), Ann A. Kiessling (Author), Susan R. Levin (Author), Susan L. Moss (Author), Carol A. Tauer (Author)
| List Price: | $5.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | Hastings Center | | Page Count: | 18 Pages | | Publication Date: | May 01, 2002 | | Sales Rank: | 6,762,779th |
|
EDITORIAL REVIEWS |
Product Description
This digital document is an article from The Hastings Center Report, published by Hastings Center on May 1, 2002. The length of the article is 5161 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.From the author: Advanced Cell Technology's Ethics Advisory Board has been called window dressing for a corporate marketing plan. But the scientists and managers have paid attention, and the lawyers have gone along.Citation DetailsTitle: Overseeing research on therapeutic cloning: a private ethics board responds to its critics.Author: Ronald M. GreenPublication: The Hastings Center Report (Refereed)Date: May 1, 2002Publisher: Hastings CenterVolume: 32 Issue: 3 Page: 27(8)Distributed by Thomson Gale |
|
